Our patented platform catheter technology can address multiple markets including peripheral bypass procedures, structural heart, and coronary applications.
Current Market Opportunities
CTO Re-entry device
£108m
2020
Minimally invasive bypass
£854m
2020
Minimally invasive AVF creation
£2.9b
2020
The ePATH platform catheter technology can address multiple markets including peripheral and coronary bypass procedures, structural heart, and endovascular aneurysm repair.